Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 196

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Prevalence of the Metabolic Syndrome and Its Components

Open access
Ilanne-Parikka, Pirjo, Eriksson, Johan G., Lindström, Jaana, Hämäläinen, Helena, Keinänen-Kiukaanniemi, Sirkka, Laakso, Mauri, Louheranta, Anne, Mannelin, Marjo, Rastas, Merja, Salminen, Virpi, Aunola, Sirkka, Sundvall, Jouko, Valle, Timo, Lahtela, Jorma, Uusitupa, Matti, Tuomilehto, Jaakko, the Finnish Diabetes Prevention Study Group · 2004 · Diabetes Care

Abstract

OBJECTIVE—To assess the prevalence of the metabolic syndrome (MetS) in two independent Finnish study cohorts. RESEARCH DESIGN AND METHODS—The prevalence of the MetS by modified World Health Organization criteria was analyzed in different categories of glucose tolerance in a cross-sectional, population-based sample of 2,049 individuals (FINRISK) aged 45–64 years and in 522 participants of the Finnish Diabetes Prevention Study (DPS) with impaired glucose tolerance (IGT). RESULTS—In the FINRISK cohort, the MetS was present in 38.8% of the men and 22.2% of the women. The prevalence was 14.4 and 10.1% in subjects with normal glucose tolerance, 74.0 and 52.2% in subjects with impaired fasting glucose, 84.8 and 65.4% in subjects with IGT, and 91.5 and 82.7% in subjects with type 2 diabetes in men and women, respectively. Among women, the prevalence of the MetS increased with increasing age. In the DPS cohort, the MetS was present in 78.4% of the men and 72.2% of the women with IGT. CONCLUSIONS—The MetS was extremely common in middle-aged subjects The high prevalence in men was mostly due to their high waist-to-hip ratio. The prevalence of the MetS increased in both sexes with deterioration in glucose regulation. Approximately 75% of the subjects with IGT had the MetS. Because the syndrome includes the major risk factors for atherosclerotic vascular diseases and is the major antecedent for type 2 diabetes, concerted preventive action should be targeted to control all the features of the MetS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/diacare.27.9.2135

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 196

Metadata

Authors
Ilanne-Parikka, P., Eriksson, J. G., Lindström, J., Hämäläinen, H., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Mannelin, M., Rastas, M., Salminen, V., Aunola, S., Sundvall, J., Valle, T., Lahtela, J., Uusitupa, M., Tuomilehto, J., & the Finnish Diabetes Prevention Study Group
Venue
Diabetes Care
Published
2004-09-01
Volume
27
Issue
9
Pages
2135-2140
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2099789671
Cited by
196
References
9
FWCI
11.45
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prevalence of the Metabolic Syndrome and Its Components. https://app.cochat.ai/papers/10.2337/diacare.27.9.2135
The paper
Ilanne-Parikka, P., Eriksson, J. G., Lindström, J., Hämäläinen, H., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Mannelin, M., Rastas, M., Salminen, V., Aunola, S., Sundvall, J., Valle, T., Lahtela, J., Uusitupa, M., Tuomilehto, J., & the Finnish Diabetes Prevention Study Group. (2004). Prevalence of the Metabolic Syndrome and Its Components. Diabetes Care. https://doi.org/10.2337/diacare.27.9.2135

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.